Advertisements

VistaGen Therapeutics Inc. (VTGN) Stock Quote

Detailed Quote for VistaGen Therapeutics Inc. (VTGN)
$ 1.04   -0.06 (-5.45%) Volume: 718.06k 4:00 PM EST Dec 15, 2017
After Hours:  $ 1.04 0.00 (0.00%) Volume: 53 4:47 PM EST Dec 15, 2017
Today 5d 1m 3m 1y more
Last Price
1.04
Change $
0.06
Change %
5.45%
Tick
  
Bid
0.00
Bid Size
0
Ask
0.00
Ask Size
0
Open
1.12
High
1.12
Low
1.02
Prev Close
1.10
Last Trade
12/15/17
Volume
718.06k
52 Wk Hi
3.90000009
52 Wk Low
0.689999997
Market Cap
12.17m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
11,698,974
EPS (TTM)
-1.45000004
PE Ratio
N/A
Exchange
NCM
News and Media for VistaGen Therapeutics Inc. (VTGN)
Sector News | Topic News
News for VistaGen Therapeutics Inc. (VTGN)
Wed, Dec 13, 2017
4:31 PM VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock - Marketwired
4:31 PM VistaGen Announces Closing of $15,000,000 Underwritten Offering of Common Stock and Warrants to Purchase Common Stock - Marketwired
Tue, Dec 12, 2017
7:30 AM Wired News - VistaGen Receives US Patent on Methods for Producing Blood Cells, Platelets, and Bone Marrow Stem Cells - ACCESSWIRE IA
Mon, Dec 11, 2017
4:04 PM VistaGen: Risky Anti-Depression Play - SeekingAlpha
12:47 PM Midday Gainers / Losers - SeekingAlpha
9:25 AM VistaGen Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock - Marketwired
9:25 AM VistaGen Announces Pricing of Underwritten Offering of Common Stock and Warrants to Purchase Common Stock - Marketwired
9:13 AM Premarket Losers as of 9:05 am - SeekingAlpha
Fri, Dec 08, 2017
12:50 PM Midday Gainers / Losers - SeekingAlpha
9:16 AM Premarket Losers as of 9:05 am - SeekingAlpha
9:00 AM VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New U.S. Patent on Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells with Potential to Treat Autoimmune Disorders and Cancer - Marketwired
9:00 AM VistaGen Therapeutics Expands Stem Cell Patent Portfolio with New U.S. Patent on Methods for Producing Blood Cells, Platelets and Bone Marrow Stem Cells with Potential to Treat Autoimmune Disorders and Cancer - Marketwired
Thu, Dec 07, 2017
9:30 AM NetworkNewsBreaks - VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Advances IP for Lead Product Candidate with New Methods of Production Patent - NetworkNewsWire
9:22 AM Premarket Gainers as of 9:05 am - SeekingAlpha
8:05 AM VistaGen Soars on Patent Announcement, Pipeline Review, and Analysts Opinion - ACCESSWIRE IA
8:00 AM Today's Research Reports on Stocks to Watch: Madrigal Pharmaceuticals and VistaGen Therapeutics - ACCESSWIRE IA
Wed, Dec 06, 2017
9:08 AM VistaGen Therapeutics Granted U.S. Patent regarding Methods of Production for AV-101 - Marketwired
9:08 AM VistaGen Therapeutics Granted U.S. Patent regarding Methods of Production for AV-101 - Marketwired
Sat, Nov 25, 2017
8:18 AM Stocks to watch next week - SeekingAlpha
Thu, Nov 09, 2017
4:46 PM VistaGen Therapeutics reports Q3 results - SeekingAlpha
More News for VTGN >>

Tags for VistaGen Therapeutics Inc.

Research stocks or mutual funds related to VistaGen Therapeutics Inc. by keywords or tags. Find companies that have a similar focus to VTGN. The keywords below have been associated to VTGN by either user submission or electronic means.